2021 Conference - Call for Symposia and Workshops
0 comments
by Thomas Willett
Dear members and friends of CBS, As part of planning the program for the 36th Canadian Biomaterials Society CBS conference, we invite members and sponsors to submit proposals for symposia and or workshops...
CBS Mentorship Program (2020-2021 academic year)
0 comments
by Kibret Mequanint
Dear CBS Member Trainees, We are very pleased to launch the call for applications for the CBS Mentorship and Professional Development Program for the second year...
Trends in Bioabsorbable Metals 2020 Where Science meets Technology and Clinics August 24 and 25, 2020 A Virtual Symposium Online, informative, affordable http www...
Weekly Conference on Biomaterials and Pharmaceutic
0 comments
by Todd Hoare
Hello, The Canadian Society of Biomaterials and the Student Chapters of Quebec and Montreal are pleased to invite you to Weekly Conference on Biomaterials in Pharmaceutics ...
Polymer coatings or bulk materials modified with photo-responsive molecules whose properties change in response to different wavelengths of light could enable shifts in cell-material interactions1 at device interfaces after implantation...
Peripheral arterial disease is a chronic condition caused by the formation and hardening of fatty plaque within arteries and arterioles, resulting in narrowing or blocking of the vessels carrying blood to the limbs...
Tissue engineering is an advancing field due in part to the development of polymers in geometries and dimensions similar to those found in the native extracellular matrix...
Recently, microfabrication technologies have been used for the development of blood oxygenators to treat neonates with respiratory distress and to overcome the limitations of extracorporeal membrane oxygenation ECMO and mechanical ventilation1,2...
Alternatives to existing implantable materials ex. metals or autologous grafts for bone tissue repair and regeneration are needed to improve patient outcomes and avoid the complications caused by issues such as stress shielding and donor site morbidity 1 ...